SYDNEY, Australia, Aug. 04, 2023 (GLOBE NEWSWIRE) Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), the Company developing a new class of synthetic anti-infectives, is pleased to announce the Australian Patent Office has formally granted Recce a new family four patent, “Process for Preparation of Biologically Active Copolymer,” with expiry in 2041. “We are thrilled to receive this new family of intellectual property, granted by the Australian Patent Office, with further market monopolies reinfo
Recce Pharmaceuticals Granted New Anti-Viral Patent in Australia for RECCE® Anti-Infectives tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) CEO James Graham tells Proactive that the company has been given a boost from the Australian Patent Office,.
Recce Pharmaceuticals Ltd welcomes 'intent to grant' Family 4 patent for anti-infectives proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
Recce Pharmaceuticals Ltd CEO James Graham tells Proactive that the company has been given a boost from the Australian Patent Office, which has issued notification of ‘intent to grant’. | April 11, 2023